Patents-Review.com
🔗 Permalink
Assignee profile:

BIOVEC, LLC

City:

CHICAGO, Illinois

Country:

United States

Published Applications:

17

Last publication date:

2011-12-15

Patent Grants:

17

Last grant date:

2016-05-31

Top Inventors for applications by BIOVEC, LLC

These are the the leading inventors for applications assigned to BIOVEC, LLC:

Recent patent applications by BIOVEC, LLC

BIOVEC, LLC based in CHICAGO, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2011-12-15 ✅ Patent 9,353,383 granted on 2016-05-31
US20110307076A1
Chemistry; metallurgy

Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #2 | 2011-08-11 ✅ Patent 8,236,300 granted on 2012-08-07
US20110196023A1
Chemistry; metallurgy

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #3 | 2011-08-11 ✅ Patent 8,367,056 granted on 2013-02-05
US20110196022A1
Chemistry; metallurgy

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #4 | 2010-09-30 ✅ Patent 8,048,410 granted on 2011-11-01
US20100249221A1
Chemistry; metallurgy

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #5 | 2010-09-30 ✅ Patent 8,242,095 granted on 2012-08-14
US20100247487A1
Chemistry; metallurgy

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #6 | 2010-09-23 ✅ Patent 8,420,075 granted on 2013-04-16
US20100240740A1
Chemistry; metallurgy

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

 #7 | 2009-10-22 ✅ Patent 8,142,992 granted on 2012-03-27
US20090263781A1
Human necessities

Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier

 #8 | 2009-10-08 ✅ Patent 8,129,104 granted on 2012-03-06
US20090253115A1
Human necessities

Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobin

 #9 | 2009-09-24 ✅ Patent 9,388,427 granted on 2016-07-12
US20090238795A1
Chemistry; metallurgy

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors

 #10 | 2009-05-14 ✅ Patent 7,713,522 granted on 2010-05-11
US20090123440A1
Human necessities

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

 #11 | 2009-04-23 ✅ Patent 7,687,058 granted on 2010-03-30
US20090105180A1
Human necessities

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

 #12 | 2008-09-25 ✅ Patent 8,129,103 granted on 2012-03-06
US20080233554A1
Human necessities

Use of a platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier

 #13 | 2007-10-11 ✅ Patent 7,803,365 granted on 2010-09-28
US20070238685A1
Chemistry; metallurgy

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

 #14 | 2007-09-13 ✅ Patent 7,481,998 granted on 2009-01-27
US20070212334A1
Human necessities

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

 #15 | 2007-08-09 ✅ Patent 7,501,114 granted on 2009-03-10
US20070184027A1
Human necessities

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

 #16 | 2007-02-20 ✅ Patent 7,179,459 granted on 2007-02-20
US10725013
-

and expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

 #17 | 2006-12-21 ✅ Patent 7,670,597 granted on 2010-03-02
US20060286083A1
Human necessities

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
AssigneeID:

215711 ⎘